American Journal of Kidney Diseases
Volume 53, Issue 1 , Pages 9-11 , January 2009

Blood Pressure and Mortality Risk in Patients Treated by Peritoneal Dialysis

  • Philip G. Zager, MD

      Affiliations

    • University of New Mexico Health Sciences Center, Albuquerque, New Mexico
    • Dialysis Clinic, Inc, Albuquerque, New Mexico
    • Corresponding Author InformationAddress correspondence to Philip G. Zager, MD, Dialysis Clinic, Inc Quality Management, 1500 Indian School Rd NE, Albuquerque, NM 87102
    • ,
  • Mark R. Rohrscheib, MD

      Affiliations

    • University of New Mexico Health Sciences Center, Albuquerque, New Mexico
    • Dialysis Clinic, Inc, Albuquerque, New Mexico

References 

  1. Tentori F, Hunt WC, Rohrscheib M, et al. Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization?. J Am Soc Nephrol. 2007;18:2377–2384
  2. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population (Results from the Third National Health and Nutrition Examination Survey, 1988-1991). Hypertension. 1995;25:305–313
  3. Klassen PS, Lowrie EG, Reddan DN, et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA. 2002;287:1548–1555
  4. Mange KC, Feldman HI, Joffe MM, Fa K, Bloom RD. Blood pressure and the survival of renal allografts from living donors. J Am Soc Nephrol. 2004;15:187–193
  5. Opelz G, Dohler B. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant. 2005;5:2725–2731
  6. Udayaraj UP, Steenkamp R, Caskey FJ. Blood pressure and mortality risk on peritoneal dialysis. Am J Kidney Dis. 2009;53:70–78
  7. Stidley CA, Hunt WC, Tentori F, et al. Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol. 2006;17:513–520
  8. NHS National Institute for Health and Clinical Excellence. Type 2 Diabetes National Clinical Guideline for Management in primary and secondary care. Royal College of Physicians. 2008;151–179
  9. Arauz-Pacheco C, Parrott MA, Raskin P. Hypertension management in adults with diabetes. Diabetes Care. 2004;27(suppl 1):S65–S67
  10. Bloch MJ, Basile J. AHA scientific statement: new blood pressure targets for high-risk and established coronary artery disease patients. J Clin Hypertens (Greenwich). 2007;9:649–651
  11. National Kidney Foundation. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;43:S1–S290
  12. UK Renal Registry 2007. Comparison of UK Registry Data with Other National Renal Registries. http://www.renalreg.com//wp-content/themes/renalregistry/pdf/Report%202007/Chapter12.pdfAccessed September 29, 2008
  13. Rohrscheib MR, Myers OB, Servilla KS, et al. Age-related blood pressure patterns and blood pressure variability among hemodialysis patients. Clin J Am Soc Nephrol. 2008;3:1407–1414
  14. Anand IS, Tam SW, Rector TS, et al. Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial. J Am Coll Cardiol. 2007;49:32–39

PII: S0272-6386(08)01566-7

doi: 10.1053/j.ajkd.2008.10.036

American Journal of Kidney Diseases
Volume 53, Issue 1 , Pages 9-11 , January 2009

Article Tools